The goal is to support digestion while the body adapts to the medication without stopping treatment altogether
Herbster L, Pander G, Bhmann M, Eisenzapf T, Wohlfart S, Mhlberg E, et al
[22] Peptides with pharmacological activity intended for human use including growth hormone secretagogues are likely to be classified as POMs by default if they were licensed, and their unlicensed supply for human use is therefore unlawful
For those curious about newer options, the three-way comparison between semaglutide, tirzepatide, and retatrutide provides a broader view of the GLP-1 medication landscape and how costs compare across the category
Equally, Nooms clinician-designed protocol recognizes that a higher dose isnt always better for every patient
Safety-wise, this ingredient is pretty solid